Interestingly, 6 modestly inhibited (by 20–25 %) two but not all the four tested PI3K isoforms, suggesting that the current strategy for PIPK inhibition might be applied to develop isoform‐specific inhibitor of PI3Ks, which hold great potential to treat cancers.[22]. This evidence concerns the gene PIP4K2A and cancer.